Literature DB >> 3021983

Reassortant rotaviruses containing structural proteins vp3 and vp7 from different parents induce antibodies protective against each parental serotype.

P A Offit, H F Clark, G Blavat, H B Greenberg.   

Abstract

Genetic studies of reassortant rotaviruses have demonstrated that gene segments 4 and 9 each segregate with the serotype-specific neutralization phenotype in vitro. Reassortant rotaviruses derived by coinfection of MA-104 cells with the simian strain SA11 and the antigenically distinct bovine strain NCDV were used to determine which viral genes coded for proteins which induced a protective immune response in vivo. In addition, reassortant rotaviruses containing only the gene segment 4 or 9 protein products (vp3 and vp7, respectively) from SA11 or NCDV were used to determine the serotypic specificities of both vp3 and vp7 in several mammalian rotavirus strains. vp3 and vp7 from the murine strain Eb were shown to be indistinguishable from the corresponding proteins from strain SA11. Adult mice orally inoculated with strain Eb developed neutralizing antibodies to both vp3 and vp7. The two naturally occurring bovine rotavirus strains NCDV and UK were shown to contain antigenically similar vp7 but distinct vp3 proteins. Mouse dams orally immunized with a reassortant virus containing only gene 9 from NCDV passively protected their progeny against UK challenge, whereas mouse dams orally immunized with a reassortant virus containing only gene 4 from NCDV did not. Finally, we constructed reassortant viruses that immunized against rotaviruses of two distinct serotypes. SA11 X NCDV reassortants that contained vp3 and vp7 from different parents induced a protective immune response against both parental serotypes. vp3 and vp7 were independently capable of inducing a protective immune response after oral immunization. An understanding of the serotypic specificities of both vp3 and vp7 of human rotavirus isolates will be necessary for the development of successful strategies to protect infants against severe rotavirus infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021983      PMCID: PMC288917     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Semiautomatic apparatus for milking mice.

Authors:  W F Feller; J Boretos
Journal:  J Natl Cancer Inst       Date:  1967-01       Impact factor: 13.506

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens.

Authors:  A R Kalica; H B Greenberg; R G Wyatt; J Flores; M M Sereno; A Z Kapikian; R M Chanock
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

4.  The cultivation of human rotavirus, strain 'Wa', to high titer in cell culture and characterization of the viral structural polypeptides.

Authors:  P A Offit; H F Clark; W G Stroop; E M Twist; S A Plotkin
Journal:  J Virol Methods       Date:  1983-07       Impact factor: 2.014

5.  In vitro transcription and translation of simian rotavirus SA11 gene products.

Authors:  B B Mason; D Y Graham; M K Estes
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

6.  Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children.

Authors:  A Z Kapikian; H W Kim; R G Wyatt; W L Cline; J O Arrobio; C D Brandt; W J Rodriguez; D A Sack; R M Chanock; R H Parrott
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

7.  A murine model for oral infection with a primate rotavirus (simian SA11).

Authors:  P A Offit; H F Clark; M J Kornstein; S A Plotkin
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

8.  Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children.

Authors:  T Vesikari; E Isolauri; A Delem; E D'Hondt; F E André; G Zissis
Journal:  Lancet       Date:  1983-10-08       Impact factor: 79.321

9.  Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera.

Authors:  S Matsuno; S Inouye; R Kono
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

10.  A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh.

Authors:  R E Black; M H Merson; A S Rahman; M Yunus; A R Alim; I Huq; R H Yolken; G T Curlin
Journal:  J Infect Dis       Date:  1980-11       Impact factor: 5.226

View more
  76 in total

1.  Evidence of high-frequency genomic reassortment of group A rotavirus strains in Bangladesh: emergence of type G9 in 1995.

Authors:  L E Unicomb; G Podder; J R Gentsch; P A Woods; K Z Hasan; A S Faruque; M J Albert; R I Glass
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Discrete domains within the rotavirus VP5* direct peripheral membrane association and membrane permeability.

Authors:  Nina E Golantsova; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001.

Authors:  A R Laird; J R Gentsch; T Nakagomi; O Nakagomi; R I Glass
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Evidence for two serotype G3 subtypes among equine rotaviruses.

Authors:  G F Browning; R M Chalmers; T A Fitzgerald; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

5.  Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.

Authors:  P Raj; D O Matson; B S Coulson; R F Bishop; K Taniguchi; S Urasawa; H B Greenberg; M K Estes
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

6.  A novel group A rotavirus G serotype: serological and genomic characterization of equine isolate FI23.

Authors:  G F Browning; T A Fitzgerald; R M Chalmers; D R Snodgrass
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

7.  Reactivity of VP4-specific monoclonal antibodies to a serotype 4 porcine rotavirus with distinct serotypes of human (symptomatic and asymptomatic) and animal rotaviruses.

Authors:  S Y Kang; L J Saif; K L Miller
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988.

Authors:  G M Beards; U Desselberger; T H Flewett
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

9.  VP4 monotype specificities among porcine rotavirus strains of the same VP4 serotype.

Authors:  F Liprandi; I Rodriguez; C Piña; G Larralde; M Gorziglia
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Memory and distribution of virus-specific cytotoxic T lymphocytes (CTLs) and CTL precursors after rotavirus infection.

Authors:  P A Offit; S L Cunningham; K I Dudzik
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.